Introduction
The rate of gastric emptying is an important factor in determining the rate of absorption of drugs since uptake from the stomach is slow whereas absorption from the upper intestine is usually rapid (Prescott, 1974) . The rate of emptying varies from person to person and can be changed by food, posture and disease. It can also be altered by a number of different drugs particularly those which modify the actions of the autonomic nervous system (Nimmo et al., 1973; Manninen et al., 1973; Prescott, 1974) . This means that patients receiving more than one drug may fail to respond because one substance is impairing the absorption of the other. Since there are many drugs which could disturb the normal motility of the gut, the problem is to determine which preparations will increase or decrease the rate of gastric emptying to an extent which could be clinically important.
Desmethylimipramine (DMI) is an antidepressant which has some anticholinergic properties and causes dry mouth, urinary retention, constipation and drowsiness (Klerman and Cole, 1965) . It also inhibits gastric secretion in man (Baume and Powell, 1966) and studies in the rat have suggested that this is due to an action of the drug on the * Present address: Department of Human Physiology and Pharmacology, University of Adelaide, South Australia.
Correspondence and reprint requests: Dr M. J. Kendall. central nervous system (Pendleton et al., 1970; Ridley and Mann, 1973) . Since DMI has these anticholinergic effects one might anticipate that it would delay gastric emptying and thereby impair the absorption of drugs from the gut. There is some evidence that it has this effect on phenylbutazone, the serum levels of which are reduced by administration of DMI (Consolo et al., 1970) .
The work described in this paper was undertaken to determine whether DMI delays gastric emptying sufficiently to affect seriously the absorption of another drug and whether this can be predicted by examining its effect on the absorption of alcohol. Changes in the rate of absorption of alcohol can be used to detect changes in the rate of gastric emptying (Finch, Kendall and Mitchard, 1974) . We have therefore compared the effects of DMI on alcohol absorption (using a breathalyser) with its effects on the absorption of paracetamol.
Methods
The studies were carried out on six healthy male volunteers. One was taking long-term phenobarbitone and phenytoin, but the others were not on any drugs. All participants fasted 12 hr before each experiment and the same subjects were used throughout so that each subject acted as his own control.
Alcohol absorption
Each subject ingested 40 ml absolute alcohol made up to 200 ml with water and orange cordial. After ingestion, the mouth was rinsed several times with water. The blood alcohol levels were then determined by a Lions Mark II Intoximeter which measures the concentration of alcohol in the expired air. Measurements were made at 10-min intervals for up to 150 min. The experiment was subsequently repeated following the ingestion of DMI 90 min before alcohol. Two doses of DMI were used: 75 mg in six/six subjects and 25 mg in five/six subjects. In a further study four subjects took the 25 mg DMI dose 45 min before alcohol.
Paracetamol
All subjects ingested 40 mg/kg paracetamol. A cannula was inserted in an antecubital vein and blood samples (10 ml) were taken for up to 6 hr after ingestion of the drug at 10, 15, 30, 45 min, 1 0, 1-5, 20, 2-5, 30, 35, 40, 50 and 60 hr. Between samples, the cannula was perfused slowly with 0-15 mol/l saline, so that about 700-800 ml was given over the course of the 6 hr. Blood samples were centrifuged and the plasma was taken off and stored at -20°C. Analyses were carried out within 1 week of sampling. The study was subsequently repeated following the ingestion of DMI 90 min before the paracetamol. The procedure was the same as that used in the alcohol absorption studies.
Estimation of paracetamol
The plasma was extracted by the method of Berry and Grove (1973) . The extracted residue was then dissolved in redistilled ethanol and the sample read at a wavelength of 250 nm on an SP 500 u.v. Spectrophotometer (J. Grove, personal communication). Standard curves were prepared in plasma. In our hands, the reproducibility of the method in the concentrations measured was ± 2%4.
Drugs and reagents
Desmethylimipramine (Pertofran, Geigy; 25 mg tablets); paracetamol (Panadol, Winthrop; 500 mg tablets); ethanol (redistilled); ammonium sulphate (Analar grade); ether (redistilled).
Results
The effect of 75 mg DMI on the absorption of alcohol was the same as its effect on paracetamol absorption in each case. However, in five subjects, the absorption was impaired whilst in one person the administration of DMI enhanced the absorption of those substances. The results for this person, who was clinically well and not on any medication, have therefore been considered separately.
Alcohol
The effects of DMI on the absorption of alcohol in five of the six subjects are shown in Fig. 1 . In the absence of DMI, the mean peak concentration was 73-4 ± 7T1 mg/100 ml and this occurred 33-6 ± 3 0 min after ingestion of alcohol. Pre-treatment with 75 mg DMI 90 min before alcohol caused a significant reduction in the peak concentration to 47T6 ± 1 4 (P < 0 05) and a delay in the time of the peak to 53-6 ± 8-0 min. The blood alcohol levels in subjects pre-treated with 75 mg DMI were significantly lower than in controls from 30-50 min (P < 0 02) and also 60 min (P < 0-05) after ingestion. Thereafter, there was no significant difference between control and treated subjects. In four subjects the lower dose of 25 mg DMI taken 90 min before alcohol had an effect on alcohol absorption intermediate between control and 75 mg DMI. Three of these subjects also took 25 mg DMI 45 min before alcohol and there was no significant difference between the results and those obtained when 25 mg DMI was given 90 min before ingestion. In the sixth subject, DMI 25 and 75 mg taken 90 min before the alcohol increased the peak concentration of alcohol to 73 0 and 87-0 mg/100 ml respectively from a control peak 50 4 mg/100 ml. Paracetamol DMI had qualitatively similar effects on the absorption of paracetamol to those observed with alcohol. Fig. 1 shows the mean (± s.e. mean) paracetamol levels before and after DMI in five individuals. DMI, 75 mg, significantly depressed the peak concentration of paracetamol from a control of 33-6 ± 3-0 ,ug/ml to 23.8 + 4.3 (P < 0 01) and also significantly delayed the time of the peak from 50 8 + 10-8 min in controls to 187 + 45 6 min (P < 0 05) in treated subjects.
The mean plasma concentrations of paracetamol were significantly lower in DMI-treated subjects at 30 and 150 min (P < 005) and at 60 and 120 min (P < 0 02). No significant difference was detectable thereafter up to 6 hr. In three subjects, 25 mg DMI 90 min before paracetamol had an intermediate effect between control and the higher dose of DMI. The effect of DMI on paracetamol absorption in the sixth was comparable with its effect on alcohol absorption, in both doses it caused an increase in the peak concentration of paracetamol.
The peak concentrations of paracetamol and alcohol before and after 75 mg DMI are shown for individual subjects in Fig. 2 . This shows not only the anomalous behaviour of subject 6, but also demonstrates that the other results are fairly comparable. Thus, DMI markedly reduced the peaks of subject 2 but had a much smaller effect in subject 5 in both the alcohol and the paracetamol study. Figure 3 shows the correlation between peak plasma concentration of alcohol and paracetamol for all subjects and all treatments. There is a significant correlation between these peaks (r--0-66; P < 0.01).
Discussion
These results show that DMI reduces the peak concentration and delays the absorption of paracetamol. Similar effects were observed on the absorption of alcohol and, furthermore, there was a significant correlation between changes in alcohol and paracetamol concentrations providing further evidence that the breathalyser is a useful simple technique for monitoring changes in the absorption of drugs from the gastrointestinal tract (Finch, Kendall and Mitchard, 1974) . In this respect it is especially noteworthy that in the one subject in whom DMI had the unexpected effect of increasing the peak alcohol concentration a similar effect was observed on the absorption of paracetamol.
However, while changes in alcohol concentration were related to changes in paracetamol concentration, DMI had a very much more marked effect on the rate of absorption of paracetamol, for whilst the mean peak alcohol concentration was delayed by 20 min, the paracetamol peak occurred approximately 120 min later. This difference between the rate of absorption of the two drugs may be a reflection of the fact that alcohol is absorbed from the stomach, albeit slowly, while paracetamol is only absorbed to any extent from the small intestine. Because of the limited absorption of alcohol from the stomach the breathalyser may underestimate a decreased rate of absorption of drugs.
While the present study cannot fully explain the way in which DMI exerts its effect on the absorption of drugs, it is consistent with the anticholinergic properties of the drug. Reducing the dose of DMI reduced but did not abolish the effect of the drug and, furthermore, in four subjects, changing the time of administration from 90 min to 45 min before alcohol did not alter its effect on the absorption of alcohol. The observation that DMI had the opposite effect in one subject cannot be explained from the present study but emphasizes the dangers of making even qualitative generalizations on drug metabolism.
The administration of DMI not only delays the peak but also reduces the maximum concentration attained. Clinically this may be important since it implies that anticholinergic agents could prevent other drugs from ever reaching a therapeutic level in the blood. In the case of alcohol, there is some evidence that the total amount absorbed may be reduced (Finch et al., 1974) possibly because more is metabolized in the gut. However, there is insufficient evidence to make any such comment about paracetamol and we feel that the lower peak results from the slower rate of absorption leading to a flatter type of drug level/time profile. Presumably DMI not only delays the rate of gastric emptying but also reduces upper intestinal motility.
Further studies of this sort are needed since it is important to assess the effect of DMI and other preparations with anticholinergic properties on the absorption of drugs such as digoxin, anticonvulsants and antibiotics, since fluctuation in the plasma concentration of these substances may have serious clinical consequences.
